Neoral Solution
Product Images NDC 0078-0274

5 FDA label images from Novartis Pharmaceuticals Corporation · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Neoral (NDC 0078-0274). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Novartis Pharmaceuticals Corporation, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Neoral 01

Neoral 01
Neoral 100 mg Soft Gelatin Capsules (cyclosporine capsules, USP) MODIFIED carton label by Novartis Pharmaceuticals Corporation. The label shows 30 liquid-filled capsules for oral use. It includes warnings, Rx only status, barcode, and manufacturer information with the product name prominently displayed.*
FDA Label Image

Chemical Structure Of Cyclosporine (Neoral 02)

Chemical Structure Of Cyclosporine (Neoral 02)
Chemical structure diagram of cyclosporine showing molecular components, amino acid residues, and molecular weight of 1202.63.*
FDA Label Image

Study 302 Enrolled 299 Patients With Severe Active Ra, 99% Of Whom Were Unresponsive Or Intolerant To At Least One Prior Major Ra Drug. Patients Were Randomized To 1 Of 2 Treatment Groups (1) Neoral® And (2) Cyclosporine, Both Of Which Were Started At 2.5 mg/kg/day And Increased After 4 Weeks For Inefficacy In Increments Of 0.5 mg/kg/day To A Maximum Of 5 mg/kg/day And Decreased At Any Time For Toxicity. Treatment Duration Was 24 Weeks. The Mean Cyclosporine Dose At The Last Visit Was 2.91 mg/kg/day (range: 0.72-5.17) For Neoral® And 3.27 mg/kg/day (range: 0.73 5.68) For Cyclosporine. (Neoral 03)

Study 302 Enrolled 299 Patients With Severe Active Ra, 99% Of Whom Were Unresponsive Or Intolerant To At Least One Prior Major Ra Drug. Patients Were Randomized To 1 Of 2 Treatment Groups (1) Neoral® And (2) Cyclosporine, Both Of Which Were Started At 2.5 mg/kg/day And Increased After 4 Weeks For Inefficacy In Increments Of 0.5 mg/kg/day To A Maximum Of 5 mg/kg/day And Decreased At Any Time For Toxicity. Treatment Duration Was 24 Weeks. The Mean Cyclosporine Dose At The Last Visit Was 2.91 mg/kg/day (range: 0.72-5.17) For Neoral® And 3.27 mg/kg/day (range: 0.73 5.68) For Cyclosporine. (Neoral 03)
A bar graph titled 'ACR Responders Randomized' comparing different treatment groups including CsA (cyclosporine), Mtx, placebo, Neoral, and combinations thereof across several study groups. The vertical axis shows a percentage scale from 0% to 50%. P-values indicating statistical significance versus placebo or comparator are displayed above bars. The graph visually represents response rates for these treatments in clinical trial groups numbered 651, 652, 2008, 654, and 302.*
FDA Label Image

Principal Display Panel – Package Label – 25 mg Soft Gelatin Capsules (Neoral 04)

Principal Display Panel – Package Label – 25 mg Soft Gelatin Capsules (Neoral 04)
Neoral 25 mg Soft Gelatin Capsules packaging label for cyclosporine capsules, USP MODIFIED, by Novartis Pharmaceuticals Corporation. The label indicates a 30-count carton of oral liquid-filled capsules and includes directions and warnings about the medication's use. The label shows the product name, strength, dosage form, and manufacturer information.*
FDA Label Image

Principal Display Panel – Package Label – 100 mg Soft Gelatin Capsules (Neoral 05)

Principal Display Panel – Package Label – 100 mg Soft Gelatin Capsules (Neoral 05)
Neoral Oral Solution 100 mg/mL (cyclosporine oral solution, USP) MODIFIED is a liquid-filled oral capsule product label by Novartis Pharmaceuticals Corporation. The label includes dosing instructions, warnings about interchangeability with Sandimmune, storage directions, and manufacturer details. The packaging is primarily white with blue and purple text and features a drop symbol indicating the liquid form.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.